InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Foley Todd, Director. Officer active across 3 companies, notably Repare Therapeutics Inc.. In total, 14 reports have been logged. Breakdown: 0 buy · 12 sells. Total volume traded: €5.4m. History available since 18 May 2021. The latest transaction was filed on 9 July 2021 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Foley Todd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
597,391 sharesCommon StockSEC:0001473930-26-000005:0
3,816,760 sharesCommon StockSEC:0001209191-21-062981:0
1,792 shares@ US$33.060.9% of flowCommon SharesSEC:0001209191-21-046493:0
6,080 shares@ US$34.063.2% of flowCommon SharesSEC:0001209191-21-044005:0
2,697 shares@ US$33.531.4% of flowCommon SharesSEC:0001209191-21-043473:0
2,556 shares@ US$33.801.3% of flowCommon SharesSEC:0001209191-21-042802:0
13,575 shares@ US$33.787.1% of flowCommon SharesSEC:0001209191-21-041948:0
881 shares@ US$33.090.4% of flowCommon SharesSEC:0001209191-21-040963:0
3,985 shares@ US$32.802.0% of flowCommon SharesSEC:0001209191-21-039426:0
9,824 shares@ US$31.924.8% of flowCommon SharesSEC:0001209191-21-038751:0
7,377 shares@ US$32.673.7% of flowCommon SharesSEC:0001209191-21-037345:0
2,852 shares@ US$32.871.4% of flowCommon SharesSEC:0001209191-21-036354:0
133,359 shares@ US$34.8070.3% of flowCommon SharesSEC:0001209191-21-035560:0
6,509 shares@ US$33.903.3% of flowCommon SharesSEC:0001209191-21-034628:0
14 of 14 declarations
About Foley Todd
Foley Todd is Administrateur and has 14 filings in total. In the 14 sampled filings, all transactions are sales for a total of EUR 5397526, with filing dates from 2021-05-20 to 2026-01-14. The main filings concern Repare Therapeutics Inc., including EUR 3796111.45512496 on 2021-05-24, EUR 384913.5939904517 on 2021-06-21, EUR 258453.7194440663 on 2021-06-07, EUR 197656.7381807104 on 2021-06-02, EUR 180509.7775338806 on 2021-05-20, and EUR 173599.1831423178 on 2021-06-30. He is also a director of Repare Therapeutics Inc., AKTIS ONCOLOGY, INC. and Entrada Therapeutics, Inc.
